FGD5 facilitates tumor growth by regulating EGFR ubiquitination in gastric cancer

被引:8
作者
Chen, Na [1 ]
Han, Xiangdong [1 ]
Yin, Bo [1 ]
Bai, Xue [1 ]
Wang, Yubin [1 ]
机构
[1] Jinzhou Med Univ, Affiliated Hosp 1, Dept Gen Surg, Renming St 2, Jinzhou City, Liaoning, Peoples R China
关键词
FGD5; EGFR; STAT3; Gastric cancer; PROLIFERATION; EXPRESSION; SURVIVAL;
D O I
10.1016/j.bbrc.2021.04.106
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
FGD5 (faciogenital dysplasia-5), a Rho-family guanine nucleotide exchange factor, has been identified as a key regulator of endothelial cells angiogenesis and apoptosis. However, the expression and role of FGD5 in the pathogenesis of gastric cancer remain unknown. In the present study, we first detected FGD5 expression in tumor tissues of different stages by immunofluorescence and confirmed that FGD5 expression was associated with stages in human gastric cancer. Knockdown FGD5 by shRNA in 7901 and BGC823 human gastric cells lines inhibited tumorigenesis and migration in vivo and in vitro. Mechanistically, co-immunoprecipitation (Co-IP) assay showed that FGD5 interacted with EGFR and decreased EGFR ubiquitination. Additionally, FGD5 sustained the activation of EGFR downstream signaling molecules, including STAT3 and pSTAT3. Furthermore, we showed that FGD5 could induce resistance to chemotherapy 5Fu/CIS, however, a well-known STAT3 inhibitor FLL32 could reverse FGD5-induced chemotherapy resistance in vivo. In conclusion, we are the first to demonstrate that FGD5 expression was associated with tumor stage and proliferation in gastric cancer and targeting FGD5 might be a potential therapeutic target for EGFR-STAT3 resistance gastric cancer. (c) 2021 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
引用
收藏
页码:43 / 49
页数:7
相关论文
共 50 条
[41]   CDK5 suppresses the metastasis of gastric cancer cells by interacting with and regulating PP2A [J].
Lu, Jun ;
Lin, Jian-Xian ;
Zhang, Peng-Yang ;
Sun, Yu-Qin ;
Li, Ping ;
Xie, Jian-Wei ;
Wang, Jia-Bin ;
Chen, Qi-Yue ;
Cao, Long-Long ;
Lin, Yao ;
Huang, Chang-Ming ;
Zheng, Chao-Hui .
ONCOLOGY REPORTS, 2019, 41 (02) :779-788
[42]   HMGA1 facilitates tumor progression through regulating Wnt/β-catenin pathway in endometrial cancer [J].
Han, Xiuxia ;
Cao, Yanhua ;
Wang, Kun ;
Zhu, Guiping .
BIOMEDICINE & PHARMACOTHERAPY, 2016, 82 :312-318
[43]   Long Non-Coding RNA NRON promotes Tumor Proliferation by regulating ALKBH5 and Nanog in Gastric Cancer [J].
Wang, Shuchang ;
Wang, Yangyang ;
Zhang, Zizhen ;
Zhu, Chunchao ;
Wang, Chaojie ;
Yu, Fengrong ;
Zhao, Enhao .
JOURNAL OF CANCER, 2021, 12 (22) :6861-6872
[44]   AQP5 complements LGR5 to determine the fates of gastric cancer stem cells through regulating ULK1 ubiquitination [J].
Rou Zhao ;
Baoyu He ;
Qingli Bie ;
Jinghe Cao ;
Haoran Lu ;
Zhixin Zhang ;
Jing Liang ;
Li Wei ;
Huabao Xiong ;
Bin Zhang .
Journal of Experimental & Clinical Cancer Research, 41
[45]   Tepoxalin a dual 5-LOX-COX inhibitor and erlotinib an EGFR inhibitor halts progression of gastric cancer in tumor xenograft mice [J].
Lu, Xinyang ;
Huang, Lunhua ;
Zhang, Wei ;
Ning, Xiaofei .
AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2018, 10 (11) :3847-3856
[46]   Overexpression of ANXA3 is an independent prognostic indicator in gastric cancer and its depletion suppresses cell proliferation and tumor growth [J].
Wang, Ke ;
Li, Jiansheng .
ONCOTARGET, 2016, 7 (52) :86972-86984
[47]   Knockdown of EGFR inhibits growth and invasion of gastric cancer cells [J].
Zhen, Y. ;
Guanghui, L. ;
Xiefu, Z. .
CANCER GENE THERAPY, 2014, 21 (11) :491-497
[48]   The lncRNA BDNF-AS/WDR5/FBXW7 axis mediates ferroptosis in gastric cancer peritoneal metastasis by regulating VDAC3 ubiquitination [J].
Huang, Guoquan ;
Xiang, Zhenxian ;
Wu, Haitao ;
He, Qiuming ;
Dou, Rongzhang ;
Lin, Zaihuan ;
Yang, Chaogang ;
Huang, Sihao ;
Song, Jialin ;
Di, Ziyang ;
Wang, Shuyi ;
Xiong, Bin .
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022, 18 (04) :1415-1433
[49]   LncRNA TP73-AS1 accelerates tumor progression in gastric cancer through regulating miR-194-5p/SDAD1 axis [J].
Ding, Zhi ;
Lan, Haitao ;
Xu, Rui ;
Zhou, Xiang ;
Pan, Yong .
PATHOLOGY RESEARCH AND PRACTICE, 2018, 214 (12) :1993-1999
[50]   The combinational therapy of trastuzumab and cetuximab inhibits tumor growth in a patient-derived tumor xenograft model of gastric cancer [J].
Wang, C. J. ;
Tong, P. J. ;
Zhu, M. Y. .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (05) :507-514